Lista de obras -

"Caseness" for depression and anxiety in a depressed outpatient population: symptomatic outcome as a function of baseline diagnostic categories.

artículo científico publicado en 2009

A Real-World Study on Antidepressant-Associated Sexual Dysfunction in 2144 Outpatients: The SALSEX I Study

scientific article published on 21 February 2019

Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale.

artículo científico publicado en 2015

Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale.

artículo científico publicado en 2008

Clinically significant personality traits in individuals at high risk of developing psychosis.

artículo científico publicado en 2018

Consensus on Recommendations for Safe Sexual Activity during the COVID-19 Coronavirus Pandemic

artículo científico publicado en 2020

ESICM LIVES 2016: part three: Milan, Italy. 1–5 October 2016

scholarly article by T. Velasquez et al published 29 September 2016 in Intensive care medicine experimental

Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial

artículo científico publicado en 2014

Estimation of a multiattribute utility function for the Spanish version of the TooL questionnaire.

artículo científico publicado en 2011

Factors influencing depression endpoints research (FINDER): study design and population characteristics.

artículo científico publicado en 2007

Fluoxetine in the prevention of depressive recurrences: a double-blind study.

artículo científico publicado en 2001

Frequency of Sexual Dysfunction in Patients Treated with Desvenlafaxine: A Prospective Naturalistic Study.

artículo científico publicado en 2019

Functional impairment related to painful physical symptoms in patients with generalized anxiety disorder with or without comorbid major depressive disorder: post hoc analysis of a cross-sectional study

artículo científico publicado en 2011

Generalized anxiety disorder, with or without co-morbid major depressive disorder, in primary care: prevalence of painful somatic symptoms, functioning and health status.

artículo científico publicado en 2010

Hormonal Contraceptives, Female Sexual Dysfunction, and Managing Strategies: A Review

scientific article published on 25 June 2019

Influence of Personality Traits on the Severity of Alcohol Use Disorders

artículo científico publicado en 2018

Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach

artículo científico publicado en 2019

Management of physical health in patients with schizophrenia: practical recommendations.

artículo científico publicado en 2010

Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics.

artículo científico publicado en 2017

Online Porn Addiction: What We Know and What We Don't-A Systematic Review

scientific article published on 15 January 2019

Physical health considerations in psychiatry: european views on recognition, monitoring and management.

artículo científico publicado en 2008

Pornography Use in Adolescents and Its Clinical Implications

artículo científico publicado en 2020

Presence and predictors of pain in depression: results from the FINDER study.

artículo científico publicado en 2010

Prolactin awareness: an essential consideration for physical health in schizophrenia.

artículo científico publicado en 2008

Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDER.

artículo científico publicado en 2008

SSRI antidepressant use patterns and their relation to clinical global impression scores: a naturalistic study

artículo científico publicado en 1999

SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

artículo científico publicado en 1997

Sexual Dysfunction and Quality of Life in Chronic Heroin-Dependent Individuals on Methadone Maintenance Treatment

scientific article published on 07 March 2019

Sexual behaviour and risk of sexually transmitted infections in young female healthcare students in Spain

artículo científico publicado en 2016

Sexual disorders beyond DSM-5: the unfinished affaire.

artículo científico publicado en 2017

Sexual function during long-term duloxetine treatment in patients with recurrent major depressive disorder.

artículo científico publicado en 2010

Sexual function in chronic illness.

artículo científico publicado en 2010

Sexual quality of life in gender-dysphoric adults before genital sex reassignment surgery

artículo científico publicado en 2014

Sexuality and Mental Health: The Need for Mutual Development and Research

artículo científico publicado en 2019

Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia.

artículo científico publicado en 2016

Subjective perception of cognitive deficit in psychotic patients.

artículo científico publicado en 2006

Systematic depression screening in high-risk patients attending primary care: a pragmatic cluster-randomized trial ⬇️

artículo científico publicado el 13 de marzo de 2013

Tardive Dyskinesia After Aripiprazole Treatment That Improved With Tetrabenazine, Clozapine, and Botulinum Toxin

artículo científico publicado en 2019

The costs of schizophrenia in Spain.

artículo científico publicado en 2006

The effects of agomelatine on sexual function in depressed patients and healthy volunteers ⬇️

artículo científico publicado el 21 de noviembre de 2011

The socioeconomic costs of mental illness in Spain.

artículo científico publicado en 2008

Understanding the Mechanism of Antidepressant-Related Sexual Dysfunction: Inhibition of Tyrosine Hydroxylase in Dopaminergic Neurons after Treatment with Paroxetine but Not with Agomelatine in Male Rats

artículo científico publicado en 2019

Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study.

artículo científico publicado en 2005

Usefulness of the CAPE-P15 for detecting people at ultra-high risk for psychosis: Psychometric properties and cut-off values.

artículo científico publicado en 2017

Validation of a specific measure to assess health-related quality of life in patients with schizophrenia and bipolar disorder: the 'Tolerability and quality of life' (TOOL) questionnaire ⬇️

artículo científico publicado el 11 de marzo de 2011

[Durability of the effects of a quality improvement intervention in hypertensive patients on long-term follow-up (CICLO-RISK study)]

scientific article published on 15 May 2009

[Sexual dysfunction associated to the use of psychodrugs. Present importance and therapeutic possibilities]

scientific article published on 01 April 1999

Lista de obras de

"Caseness" for depression and anxiety in a depressed outpatient population: symptomatic outcome as a function of baseline diagnostic categories.

A Real-World Study on Antidepressant-Associated Sexual Dysfunction in 2144 Outpatients: The SALSEX I Study

Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale.

Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale.

Clinically significant personality traits in individuals at high risk of developing psychosis.

Consensus on Recommendations for Safe Sexual Activity during the COVID-19 Coronavirus Pandemic

ESICM LIVES 2016: part three: Milan, Italy. 1–5 October 2016

Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial

Estimation of a multiattribute utility function for the Spanish version of the TooL questionnaire.

Factors influencing depression endpoints research (FINDER): study design and population characteristics.

Fluoxetine in the prevention of depressive recurrences: a double-blind study.

Frequency of Sexual Dysfunction in Patients Treated with Desvenlafaxine: A Prospective Naturalistic Study.

Functional impairment related to painful physical symptoms in patients with generalized anxiety disorder with or without comorbid major depressive disorder: post hoc analysis of a cross-sectional study

Generalized anxiety disorder, with or without co-morbid major depressive disorder, in primary care: prevalence of painful somatic symptoms, functioning and health status.

Hormonal Contraceptives, Female Sexual Dysfunction, and Managing Strategies: A Review

Influence of Personality Traits on the Severity of Alcohol Use Disorders

Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach

Management of physical health in patients with schizophrenia: practical recommendations.

Multidisciplinary consensus on the therapeutic recommendations for iatrogenic hyperprolactinemia secondary to antipsychotics.

Online Porn Addiction: What We Know and What We Don't-A Systematic Review

Physical health considerations in psychiatry: european views on recognition, monitoring and management.

Pornography Use in Adolescents and Its Clinical Implications

Presence and predictors of pain in depression: results from the FINDER study.

Prolactin awareness: an essential consideration for physical health in schizophrenia.

Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDER.

SSRI antidepressant use patterns and their relation to clinical global impression scores: a naturalistic study

SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

Sexual Dysfunction and Quality of Life in Chronic Heroin-Dependent Individuals on Methadone Maintenance Treatment

Sexual behaviour and risk of sexually transmitted infections in young female healthcare students in Spain

Sexual disorders beyond DSM-5: the unfinished affaire.

Sexual function during long-term duloxetine treatment in patients with recurrent major depressive disorder.

Sexual function in chronic illness.

Sexual quality of life in gender-dysphoric adults before genital sex reassignment surgery

Sexuality and Mental Health: The Need for Mutual Development and Research

Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia.

Subjective perception of cognitive deficit in psychotic patients.

Systematic depression screening in high-risk patients attending primary care: a pragmatic cluster-randomized trial ⬇️

Tardive Dyskinesia After Aripiprazole Treatment That Improved With Tetrabenazine, Clozapine, and Botulinum Toxin

The costs of schizophrenia in Spain.

The effects of agomelatine on sexual function in depressed patients and healthy volunteers ⬇️

The socioeconomic costs of mental illness in Spain.

Understanding the Mechanism of Antidepressant-Related Sexual Dysfunction: Inhibition of Tyrosine Hydroxylase in Dopaminergic Neurons after Treatment with Paroxetine but Not with Agomelatine in Male Rats

Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study.

Usefulness of the CAPE-P15 for detecting people at ultra-high risk for psychosis: Psychometric properties and cut-off values.

Validation of a specific measure to assess health-related quality of life in patients with schizophrenia and bipolar disorder: the 'Tolerability and quality of life' (TOOL) questionnaire ⬇️

[Durability of the effects of a quality improvement intervention in hypertensive patients on long-term follow-up (CICLO-RISK study)]

[Sexual dysfunction associated to the use of psychodrugs. Present importance and therapeutic possibilities]